Skip to content
DefDex
SHINE Technologies logo

Startup · United States

SHINE Technologies

HQ Janesville, WisconsinFounded 2010201-500 employees

Develops fusion technology for industrial applications, medical isotopes, and energy.

Website

Funding7 rounds · $460M

Equity raised
$460M
Debt, secondaries & grants
$32.0M
Latest
UndisclosedGrant · Aug 4, 2026
Cumulative raised$460M
Jun 28, 2021Feb 26, 2026
  • Grant
    Undisclosed
    Aug 4, 2026
  • Undisclosed
    Led by NantWorks
    Confirmed
    $240M
    Feb 26, 2026
  • Series C
    Undisclosed
    Feb 24, 2025
  • Grant
    Undisclosed
    Jan 17, 2025
  • Grant
    $32.0M
    Jul 17, 2024
  • Convertible
    $70.0M
    Oct 11, 2023
  • $150M
    Jun 28, 2021

Raised counts equity rounds; debt, secondary sales and grants are totaled separately. Amounts in other currencies are converted at the announcement month's average rate. A ~ marks an estimated or converted amount.

Capabilities1

  • Developer
    classify_sectors run 37, haiku, taxonomy 2026-10-18b: Develops fusion technology for industrial, medical isotope and energy applications, with no defense use stated.
    —Reported

Maturity and TRL describe this organization's work; the field-wide maturity is on each technology's page.

People
PersonRole
Gregory PieferFounder & CEO
Greg PieferFounder
Chris LeeChief Strategy Officer
David WillbrandChief Legal Officer
Derek KramerChief Operating Officer
Kyle StaceyCFO
Michael RossiChief Executive Officer of Shine Spect USA
Ross RadelChief Technology Officer
Todd AsmuthPresident

Sources5

Profile2

  1. 1

    The Janesville Gazette · Oct 16, 2026 · Supports Organization · news event

    “The United States Department of Energy issued a $263 million conditional loan to complete the project.”
  2. 2

    Supports Organization · linkedin url

    “https://www.linkedin.com/company/shinefusion/”

Funding2

  1. 3

    Supports Funding round, Funding round · investors, Organization

    “today announced it has raised $240 million in equity funding, and appointed Dr. Patrick Soon-Shiong, M.D., Executive Chairman of ImmunityBio and founder of NantWorks, to its Board of Directors. The round was led by NantWorks with additional participation from Fidelity Management & Research Company, Sumitomo Corporation of Americas, Pelican Energy Partners, Deerfield”
  2. 4

    LinkedIn · Supports Funding round, Organization · employee range, Organization · founded year, Organization · hq city, Organization · hq region, Organization · ownership, Role

    “funding round: Series C, 2025-02-24”

People1

  1. 5

    Supports Role

    “Greg Piefer Founder & CEO”

Each fact on this page is attached to the sources that support it. Archived copies are linked when we keep one.